Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Reduced Diarrhea

Research synthesisLow evidenceSmall effect3 studies · 1 beneficial · 2 neutral · 0 harmful

Across 3 studies on Lactobacillus reuteri DSM 17938 for reduced diarrhea, only 1 reported a statistically significant beneficial effect (moderate effect size), while 2 found neutral results with small effect sizes. The single beneficial study used a dose of 4 × 10^8 colony-forming units/day in hospitalized children aged 6–36 months with acute diarrhea. The evidence base is small, and the predominant effect across all studies is neutral with a small magnitude.

  • Effective dose range: 4 × 10^8 colony-forming units/day
  • Studied populations: children (2–5 years), hospitalized children (6–36 months) with acute diarrhea and dehydration

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. One neutral study assessed healthy children in a resource-constrained community, while the beneficial study focused on hospitalized children with clinical dehydration, limiting generalizability.

Generated Jul 21, 2026
Doses used in studies
  • CFU/day: 400 million (median 400 million, IQR 400 million400 million) 1 study
Safety in these studies
3 of 3 papers
Back to top